Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Wockhardt Ltd Board/Management Information 2022

Oct 28, 2022

59231_rns_2022-10-28_f4cb6e2d-fce8-46a4-a40b-92bb794caf94.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

28[th] October, 2022

Ref. No.: WOCK/SEC/SE/2022-23/044

==> picture [178 x 49] intentionally omitted <==

BSE Limited National Stock Exchange of India Limited Corporate Relations Department Exchange Plaza P J Towers Bandra Kurla Complex Dalal Street Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 532300 NSE Symbol: WOCKPHARMA

Dear Sir/Madam,

Sub: Intimation of the Meeting of Board of Directors of Wockhardt Limited (‘the Company’)

We wish to inform you that pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company has been convened to be held on Friday, 4[th] November, 2022, inter-alia , to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended 30[th] September, 2022.

In view of the above, the Trading window for dealing in the Shares of the Company, which was closed from 1[st] October, 2022, shall remain closed until 48 hours after the declaration of Financial Results on 4[th] November, 2022.

Kindly take the above information on record.

Thanking you,

For Wockhardt Limited

Digitally signed by Debashis Dey Debashis Dey Date: 2022.10.28 16:00:51 +05'30' Debashis Dey Company Secretary

==> picture [113 x 49] intentionally omitted <==

==> picture [513 x 32] intentionally omitted <==